| No. |
Name
Length
|
Chromosome No./Scaffold Id
Scaffold Length |
BLAST (vs nr) |
Gene ontology |
| 4231 |
O_ErmoMG16617_complete:A_ErmoMG_comp37301_c0_seq1
104bp |
|
|
| GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
| GO:0001701 |
P |
in utero embryonic development |
| GO:0004857 |
F |
enzyme inhibitor activity |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005829 |
C |
cytosol |
| GO:0006006 |
P |
glucose metabolic process |
| GO:0008361 |
P |
regulation of cell size |
| GO:0016567 |
P |
protein ubiquitination |
| GO:0032869 |
P |
cellular response to insulin stimulus |
| GO:0035264 |
P |
multicellular organism growth |
| GO:0042393 |
F |
histone binding |
| GO:0042826 |
F |
histone deacetylase binding |
| GO:0043086 |
P |
negative regulation of catalytic activity |
| GO:0045717 |
P |
negative regulation of fatty acid biosynthetic process |
| GO:0055082 |
P |
cellular chemical homeostasis |
|
| 4232 |
O_ErmoMG16618_5prime_partial:A_ErmoMG_comp37301_c0_seq2
269bp |
|
|
| GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
| GO:0001701 |
P |
in utero embryonic development |
| GO:0004857 |
F |
enzyme inhibitor activity |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005829 |
C |
cytosol |
| GO:0006006 |
P |
glucose metabolic process |
| GO:0008361 |
P |
regulation of cell size |
| GO:0016567 |
P |
protein ubiquitination |
| GO:0032869 |
P |
cellular response to insulin stimulus |
| GO:0035264 |
P |
multicellular organism growth |
| GO:0042393 |
F |
histone binding |
| GO:0042826 |
F |
histone deacetylase binding |
| GO:0043086 |
P |
negative regulation of catalytic activity |
| GO:0045717 |
P |
negative regulation of fatty acid biosynthetic process |
| GO:0055082 |
P |
cellular chemical homeostasis |
|
| 4233 |
O_ErmoMG1661_internal:A_ErmoMG_comp20293_c0_seq1
180bp |
|
PREDICTED:_protein_suppressor_of_sable_isoform_X2_[Bombyx_mori] |
|
| 4234 |
O_ErmoMG16621_5prime_partial:A_ErmoMG_comp37301_c0_seq3
311bp |
|
|
| GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
| GO:0001701 |
P |
in utero embryonic development |
| GO:0004857 |
F |
enzyme inhibitor activity |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005829 |
C |
cytosol |
| GO:0006006 |
P |
glucose metabolic process |
| GO:0008361 |
P |
regulation of cell size |
| GO:0016567 |
P |
protein ubiquitination |
| GO:0032869 |
P |
cellular response to insulin stimulus |
| GO:0035264 |
P |
multicellular organism growth |
| GO:0042393 |
F |
histone binding |
| GO:0042826 |
F |
histone deacetylase binding |
| GO:0043086 |
P |
negative regulation of catalytic activity |
| GO:0045717 |
P |
negative regulation of fatty acid biosynthetic process |
| GO:0055082 |
P |
cellular chemical homeostasis |
|
| 4235 |
O_ErmoMG16626_complete:A_ErmoMG_comp37301_c0_seq5
104bp |
|
|
| GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
| GO:0001701 |
P |
in utero embryonic development |
| GO:0004857 |
F |
enzyme inhibitor activity |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005829 |
C |
cytosol |
| GO:0006006 |
P |
glucose metabolic process |
| GO:0008361 |
P |
regulation of cell size |
| GO:0016567 |
P |
protein ubiquitination |
| GO:0032869 |
P |
cellular response to insulin stimulus |
| GO:0035264 |
P |
multicellular organism growth |
| GO:0042393 |
F |
histone binding |
| GO:0042826 |
F |
histone deacetylase binding |
| GO:0043086 |
P |
negative regulation of catalytic activity |
| GO:0045717 |
P |
negative regulation of fatty acid biosynthetic process |
| GO:0055082 |
P |
cellular chemical homeostasis |
|
| 4236 |
O_ErmoMG16628_5prime_partial:A_ErmoMG_comp37301_c0_seq6
269bp |
|
|
| GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
| GO:0001701 |
P |
in utero embryonic development |
| GO:0004857 |
F |
enzyme inhibitor activity |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005829 |
C |
cytosol |
| GO:0006006 |
P |
glucose metabolic process |
| GO:0008361 |
P |
regulation of cell size |
| GO:0016567 |
P |
protein ubiquitination |
| GO:0032869 |
P |
cellular response to insulin stimulus |
| GO:0035264 |
P |
multicellular organism growth |
| GO:0042393 |
F |
histone binding |
| GO:0042826 |
F |
histone deacetylase binding |
| GO:0043086 |
P |
negative regulation of catalytic activity |
| GO:0045717 |
P |
negative regulation of fatty acid biosynthetic process |
| GO:0055082 |
P |
cellular chemical homeostasis |
|
| 4237 |
O_ErmoMG1662_complete:A_ErmoMG_comp20301_c0_seq1
349bp |
|
putative_Wdr45l_protein_[Danaus_plexippus] |
|
| 4238 |
O_ErmoMG16631_internal:A_ErmoMG_comp37301_c0_seq7
317bp |
|
|
| GO:0000122 |
P |
negative regulation of transcription by RNA polymerase II |
| GO:0001701 |
P |
in utero embryonic development |
| GO:0004857 |
F |
enzyme inhibitor activity |
| GO:0005515 |
F |
protein binding |
| GO:0005634 |
C |
nucleus |
| GO:0005829 |
C |
cytosol |
| GO:0006006 |
P |
glucose metabolic process |
| GO:0008361 |
P |
regulation of cell size |
| GO:0016567 |
P |
protein ubiquitination |
| GO:0032869 |
P |
cellular response to insulin stimulus |
| GO:0035264 |
P |
multicellular organism growth |
| GO:0042393 |
F |
histone binding |
| GO:0042826 |
F |
histone deacetylase binding |
| GO:0043086 |
P |
negative regulation of catalytic activity |
| GO:0045717 |
P |
negative regulation of fatty acid biosynthetic process |
| GO:0055082 |
P |
cellular chemical homeostasis |
|
| 4239 |
O_ErmoMG16632_internal:A_ErmoMG_comp37302_c0_seq1
464bp |
|
|
| GO:0005737 |
C |
cytoplasm |
| GO:0007528 |
P |
neuromuscular junction development |
| GO:0007614 |
P |
short-term memory |
| GO:0008104 |
P |
protein localization |
| GO:0008355 |
P |
olfactory learning |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016319 |
P |
mushroom body development |
| GO:0042462 |
P |
eye photoreceptor cell development |
| GO:0042675 |
P |
compound eye cone cell differentiation |
| GO:0043025 |
C |
neuronal cell body |
| GO:0043204 |
C |
perikaryon |
| GO:0051018 |
F |
protein kinase A binding |
|
| 4240 |
O_ErmoMG16636_complete:A_ErmoMG_comp37303_c0_seq1
593bp |
|
|
| GO:0008152 |
P |
metabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0052689 |
F |
carboxylic ester hydrolase activity |
|
| 4241 |
O_ErmoMG16637_5prime_partial:A_ErmoMG_comp37303_c0_seq2
110bp |
|
|
|
| 4242 |
O_ErmoMG16638_complete:A_ErmoMG_comp37304_c0_seq1
207bp |
|
|
| GO:0001516 |
P |
prostaglandin biosynthetic process |
| GO:0005737 |
C |
cytoplasm |
| GO:0005783 |
C |
endoplasmic reticulum |
| GO:0005829 |
C |
cytosol |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006631 |
P |
fatty acid metabolic process |
| GO:0006633 |
P |
fatty acid biosynthetic process |
| GO:0006693 |
P |
prostaglandin metabolic process |
| GO:0016491 |
F |
oxidoreductase activity |
| GO:0016616 |
F |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| GO:0043209 |
C |
myelin sheath |
| GO:0047017 |
F |
prostaglandin-F synthase activity |
| GO:0055114 |
P |
obsolete oxidation-reduction process |
|
| 4243 |
O_ErmoMG1663_internal:A_ErmoMG_comp20307_c0_seq1
148bp |
|
hypothetical_protein_AAES_158013_[Amazona_aestiva] |
|
| 4244 |
O_ErmoMG16640_complete:A_ErmoMG_comp37305_c1_seq1
1497bp |
|
|
|
| 4245 |
O_ErmoMG16642_complete:A_ErmoMG_comp37305_c1_seq2
1359bp |
|
|
|
| 4246 |
O_ErmoMG16644_complete:A_ErmoMG_comp37305_c1_seq3
1320bp |
|
|
|
| 4247 |
O_ErmoMG16646_complete:A_ErmoMG_comp37305_c1_seq4
1458bp |
|
|
|
| 4248 |
O_ErmoMG16648_complete:A_ErmoMG_comp37306_c0_seq1
509bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4249 |
O_ErmoMG16649_complete:A_ErmoMG_comp37306_c0_seq2
508bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4250 |
O_ErmoMG1664_internal:A_ErmoMG_comp20316_c0_seq1
259bp |
|
PREDICTED:_uncharacterized_protein_LOC101738799_[Bombyx_mori] |
| GO:0005634 |
C |
nucleus |
| GO:0005654 |
C |
nucleoplasm |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016180 |
P |
snRNA processing |
| GO:0031965 |
C |
nuclear membrane |
| GO:0032039 |
C |
integrator complex |
| GO:0042795 |
P |
snRNA transcription by RNA polymerase II |
|
| 4251 |
O_ErmoMG16650_5prime_partial:A_ErmoMG_comp37306_c0_seq3
878bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4252 |
O_ErmoMG16651_5prime_partial:A_ErmoMG_comp37306_c0_seq4
428bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4253 |
O_ErmoMG16652_complete:A_ErmoMG_comp37306_c0_seq5
970bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4254 |
O_ErmoMG16653_5prime_partial:A_ErmoMG_comp37306_c0_seq6
503bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4255 |
O_ErmoMG16654_complete:A_ErmoMG_comp37306_c0_seq7
969bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4256 |
O_ErmoMG16655_5prime_partial:A_ErmoMG_comp37306_c0_seq9
362bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4257 |
O_ErmoMG16656_5prime_partial:A_ErmoMG_comp37306_c0_seq11
879bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4258 |
O_ErmoMG16657_5prime_partial:A_ErmoMG_comp37306_c0_seq12
504bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4259 |
O_ErmoMG16658_3prime_partial:A_ErmoMG_comp37306_c0_seq13
181bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
| 4260 |
O_ErmoMG16659_5prime_partial:A_ErmoMG_comp37306_c0_seq14
504bp |
|
|
| GO:0003824 |
F |
catalytic activity |
| GO:0004348 |
F |
glucosylceramidase activity |
| GO:0005886 |
C |
plasma membrane |
| GO:0006629 |
P |
lipid metabolic process |
| GO:0006665 |
P |
sphingolipid metabolic process |
| GO:0008152 |
P |
metabolic process |
| GO:0008206 |
P |
bile acid metabolic process |
| GO:0008422 |
F |
beta-glucosidase activity |
| GO:0016020 |
C |
membrane |
| GO:0016021 |
C |
integral component of membrane |
| GO:0016139 |
P |
glycoside catabolic process |
| GO:0016787 |
F |
hydrolase activity |
| GO:0016798 |
F |
hydrolase activity, acting on glycosyl bonds |
|
